Policies

privacy notice

Effective Date: 10/3/2018

This privacy notice discloses the privacy practices or www.americanriverwellnessrecover.com

This privacy notice applies solely to information collected by this website, except where stated otherwise. It will notify you of the following:

What information we collect;

With whom it is shared;

How it can be corrected;

How it is secured;

How policy changes will be communicated; and

How to address concerns over misuse of personal data

Information Collection, Use, and Sharing

We are the sole owners of the information collected on this site. We only have access to/collect information that you voluntarily give us via email or other direct contact from you. We will not sell or rent this information to anyone. We will use your information to respond to you, regarding the reason you contacted us. We will not share your information with any third party outside of our organization, other than as necessary to fulfill your request, e.g., to ship an order. Unless you ask us not to, we may contact you via email in the future to tell you about specials, new products or services, or changes to this privacy policy.

Your Access to and Control Over Information

You may opt our of any future contacts from us at any time. You can do the following at any time by contacting us via the email address or phone number provided on our website:

See what data we have about you, if any.

Change/correct any data we have about you.

Have us delete any data we have about you.

Express any concern you have about our use of your data.

Security

We take precautions to protect information. When you submit sensitive information via the website, your information is protected both online and offline. Wherever we collect sensitive information (such as credit card data), that information is encrypted and transmitted to us in a secure way. You can verify this by looking for a closed lock icon at the bottom of your web browser, or looking for “https” at the beginning of the address of the web page.

While we use encryption to protect sensitive information transmitted online, we also protect your information offline. Only employees who need the information to perform a specific job (e.g, billing or customer service) are granted access to personally identifiable information. The computers/servers on which we store personally identifiable information are kept in a secure environment.

Notification of Changes

Whenever material changes are made to the privacy notice specify how you will notify consumers.

Other Provisions as Required by Law

Numerous other provisions and/or practices may be required as a result of laws, international treaties, or industry practices. It is up to you to determine what additional practices must be followed and/or what additional disclosures are required. Please take special notice of the California Online Privacy Protection Act (CalOPPA), which is frequently amended and now includes a disclosure requirement for “Do Not Track” signals. 

If you feel that we are not abiding by this privacy policy, you should contact us immediately via telephone at 916-891-1479 or vial email.

DOT Office of drug and Alcohol policy and compliance notice

The Agricultural Improvement Act of 2018, Pub. L. 115-334, (Farm Bill) removed hemp from  the definition of marijuana under the Controlled Substances Act. Under the Farm Bill, hemp derived products containing a concentration of up to 0.3% tetrahydrocannabinol (THC) are not  controlled substances. THC is the primary psychoactive component of marijuana. Any  product, including “Cannabidiol” (CBD) products, with a concentration of more than 0.3% THC  remains classified as marijuana, a Schedule I drug under the Controlled Substances Act.  

We have had inquiries about whether the Department of Transportation-regulated safety sensitive employees can use CBD products. Safety-sensitive employees who are subject to  drug testing specified under 49 CFR part 40 (Part 40) include: pilots, school bus drivers,  truck drivers, train engineers, transit vehicle operators, aircraft maintenance personnel, fire-armed transit security personnel, ship captains, and pipeline emergency response  personnel, among others.  

It is important for all employers and safety-sensitive employees to know: 1. The Department of Transportation requires testing for marijuana and not CBD.  

  1. The labeling of many CBD products may be misleading because the products could contain higher levels of THC than what the product label states. The Food and Drug  Administration (FDA) does not currently certify the levels of THC in CBD products, so there is  no Federal oversight to ensure that the labels are accurate. The FDA has cautioned the public  that: “Consumers should beware purchasing and using any [CBD] products.” The FDA has  stated: “It is currently illegal to market CBD by adding it to a food or labeling it as a dietary  supplement.”* Also, the FDA has issued several warning letters to companies because their  products contained more CBD than indicated on the product label. **i
  2. The Department of Transportation’s Drug and Alcohol Testing Regulation, Part 40, does not  authorize the use of Schedule I drugs, including marijuana, for any reason. Furthermore, CBD  use is not a legitimate medical explanation for a laboratory-confirmed marijuana positive result.  Therefore, Medical Review Officers will verify a drug test confirmed at the appropriate cutoffs as positive, even if an employee claims they only used a CBD product.  

It remains unacceptable for any safety-sensitive employee subject to the Department of  Transportation’s drug testing regulations to use marijuana. Since the use of CBD products  could lead to a positive drug test result, Department of Transportation-regulated safety sensitive employees should exercise caution when considering whether to use CBD products. 

The contents of this document do not have the force and effect of law and are not meant to  bind the public in any way. This document is intended only to provide clarity to the public  regarding existing requirements under the law or agency policies. This policy and compliance 

notice is not legally binding in its own right and will not be relied upon by the Department as  a separate basis for affirmative enforcement action or other administrative penalty.  Conformity with this policy and compliance notice is voluntary only and nonconformity will  not affect rights and obligations under existing statutes and regulations. Safety-sensitive  employees must continue to comply with the underlying regulatory requirements for drug  testing, specified at 49 CFR part 40. 

February 18, 2020 

* What You Need to Know (And What We’re Working to Find Out) About Products Containing Cannabis  or Cannabis-derived Compounds, Including CBD: The FDA is working to answer questions about the  science, safety, and quality of products containing cannabis and cannabis-derived compounds,  particularly CBD.” https://www.fda.gov/consumers/consumer-updates/what-you-need-know-and what-were-working-find-out-about-products-containing-cannabis-or-cannabis 

** https://www.fda.gov/news-events/public-health-focus/warning-letters-and-test-results-cannabidiol related-products

Call 916-891-1479 to schedule an appointment. Same day appointments may be available. Evenings and weekends included.

Want More Information on SAP's?

Register for the DOT Clearinghouse